FDA approves generic lenacapavir for HIV prevention
The US drug agency approved the commercialization of generic lenacapavir, offering a significantly less demanding prevention method particularly for the Af
The US drug agency approved the commercialization of generic lenacapavir, offering a significantly less demanding prevention method particularly for the Af